Is Early Reimplantation of the Duodenal-Jejunal Bypass Liner Viable?

被引:6
|
作者
Leventi, Eleni [1 ,2 ]
Guenthert, Sarah J. [1 ,2 ]
Stier, Christine [3 ]
Staikov, Plamen [2 ,4 ]
Stein, Juergen [1 ,2 ]
Farrag, Karima [1 ,2 ]
机构
[1] DGD Clin Sachsenhausen, Dept Gastroenterol Clin Nutr, Schulstr 31, Frankfurt, Germany
[2] DGD Clin Sachsenhausen, Obes Ctr, Frankfurt, Germany
[3] Univ Hosp, Dept Gen Visceral Cardiovasc & Pediat Surg, Wurzburg, Germany
[4] DGD Clin Sachsenhausen, Dept Gen & Bariatr Surg, Frankfurt, Germany
关键词
Obesity; Type; 2; diabetes; Duodenal-jejunal bypass liner; Weight loss; Glycaemic control; Obesity surgery; GASTRIC BYPASS; OBESITY;
D O I
10.1007/s11695-019-03758-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
The endoscopically implanted duodenal-jejunal bypass liner (DJBL) is an impermeable fluoropolymer device which prevents food making contact with the proximal intestine, thus inducing weight loss and improvement of type 2 diabetes mellitus (T2DM). However, weight and HbA1c levels generally increase post explantation. This study investigated the safety and feasibility of early DJBL reimplantation in five patients with obesity whose glucose levels had relapsed post explantation, examining the effect of reimplantation on weight loss, BMI and T2DM management. All DJBL implantation and explantation procedures were performed without complications. Despite reduction of T2DM medications, reduction in body weight and HbA1c levels resumed after reimplantation. In conclusion, early reimplantation of DJBL appears feasible, safe and effective.
引用
收藏
页码:1690 / 1693
页数:4
相关论文
共 50 条
  • [41] Is Systemic Inflammation Not Involved in Endoscopic Duodenal-Jejunal Bypass Liner-Induced Diabetes Remission?
    Cheng-I Wu
    Wei-Jei Lee
    Chih-Yen Chen
    Obesity Surgery, 2014, 24 : 2001 - 2002
  • [42] Is Systemic Inflammation Not Involved in Endoscopic Duodenal-Jejunal Bypass Liner-Induced Diabetes Remission?
    Wu, Cheng-I
    Lee, Wei-Jei
    Chen, Chih-Yen
    OBESITY SURGERY, 2014, 24 (11) : 2001 - 2002
  • [43] The Duodenal-Jejunal Bypass Liner for the Treatment of Type 2 Diabetes Mellitus and/or Obesity: a Systematic Review
    Zechmeister-Koss, Ingrid
    Huic, Mirjana
    Fischer, Stefan
    OBESITY SURGERY, 2014, 24 (02) : 310 - 323
  • [44] WHAT HAPPENS TO WEIGHT AND TYPE 2 DIABETES AFTER EXPLANTATION OF THE DUODENAL-JEJUNAL BYPASS LINER?
    Betzel, Bark
    Homan, Jens
    Schijns, Wendy
    Deden, Laura
    van Rens, Michiel
    Aarts, Edo
    Janssen, Ignace
    Wahab, Peter
    Groenen, Marcel
    Berends, Frits
    OBESITY SURGERY, 2015, 25 : S55 - S56
  • [45] Clinical Experience With a Second Generation, 6 Month Duration, Endoscopic, Duodenal-Jejunal Bypass Liner
    Escalona, Alex
    Anrique, Luis I.
    Pimentel, Frenando
    Sharp, Allan C.
    Galvao, Manoel
    Gersin, Keith S.
    GASTROINTESTINAL ENDOSCOPY, 2010, 71 (05) : AB200 - AB201
  • [46] Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomes
    Colas, Ana
    Varela, Manuel
    Mraz, Milos
    Novak, Daniel
    Cuesta-Frau, David
    Vigil, Luis
    Benes, Marek
    Pelikanova, Terezie
    Haluzik, Martin
    Burda, Vaclav
    Vargas, Borja
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (04)
  • [47] Duodenal-Jejunal Bypass Liner to Treat Type 2 Diabetes Mellitusin Morbidly Obese Patients
    Munoz, Rodrigo
    Escalona, Alex
    CURRENT CARDIOLOGY REPORTS, 2014, 16 (03)
  • [48] Improvement of Type 2 Diabetes after Implantation of a Duodenal-Jejunal Bypass Liner in Obese Patients
    Betzel, B.
    Koehestanie, P.
    Dogan, K.
    Janssen, I.
    Wahab, P.
    Berends, F.
    de Boer, H.
    OBESITY SURGERY, 2013, 23 (08) : 1179 - 1180
  • [49] Weight reduction and improvement in diabetes by the duodenal-jejunal bypass liner: a 198 patient cohort study
    Bark Betzel
    Jens Homan
    Edo O. Aarts
    Ignace M. C. Janssen
    Hans de Boer
    Peter J. Wahab
    Marcel J. M. Groenen
    Frits J. Berends
    Surgical Endoscopy, 2017, 31 : 2881 - 2891
  • [50] Research Progress of Duodenal-Jejunal Bypass Liner in the Treatment of Obesity and Type 2 Diabetes Mellitus
    Chen, Ji-Hua
    Yu, Zi-Han
    Liu, Qin-Ling Fei
    Meng, Qing-Guo
    Chen, Xin
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2022, 15 : 3319 - 3327